Beijing Strong Biotechnologies,Inc. (SHE:300406)
12.57
+0.11 (0.88%)
Nov 2, 2026, 1:25 PM CST
SHE:300406 Revenue
Beijing Strong Biotechnologies,Inc. had revenue of 351.44M CNY in the quarter ending September 30, 2026, with 2.35% growth. This brings the company's total for the last twelve months to 1.37B, down -4.14% year-over-year. In the year 2025, Beijing Strong Biotechnologies,Inc. had annual revenue of 1.36B, down -18.29%. That makes Beijing Strong Biotechnologies,Inc. the 17,288th largest company in the world by revenue and 3,145th in China.
Revenue (ttm)
1.37B
Revenue Growth
-4.14%
P/S Ratio
5.30
Revenue / Employee
1.38M
Employees
998
Market Cap
7.35B
Revenue by Geography
- China 1.30B 95.8%
- Foreign 56.62M 4.2%
Fiscal year ended Dec 31, 2025 See the full SHE:300406 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.36B | -303.42M | -18.29% |
| Dec 31, 2024 | 1.66B | -82.69M | -4.75% |
| Dec 31, 2023 | 1.74B | 230.75M | 15.27% |
| Dec 31, 2022 | 1.51B | -88.51M | -5.53% |
| Jan 1, 2022 | 1.60B | 751.27M | 88.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 9.94B |
| Shanghai Runda Medical Technology | 6.52B |
| Guangzhou Kingmed Diagnostics Group | 5.89B |
| BGI Genomics | 3.72B |
| Maccura Biotechnology Co.Ltd | 2.18B |
| Medicalsystem Biotechnology | 1.68B |
| Shanghai Labway Clinical Laboratory | 1.28B |
| Amoy Diagnostics | 1.20B |